PATENT CLAIM ANALYSIS

Application Number: 15909617
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "009700"]

Abstract:
The present invention relates, inter alia, to a method comprising administering to a subject having high output shock and undergoing treatment with a catecholamine at a dose equivalent to at least about 0.2 mcg/kg/min of norepinephrine a dose of angiotensin II which is effective to raise the blood pressure of the subject to a mean arterial pressure (MAP) of about 65 mm Hg or above, and which is effective to reduce the dose of the catecholamine required to maintain a MAP of about 65 mm Hg to the equivalent of about 0.05-0.2 mcg/kg/min norepinephrine or less, or to the equivalent of about 0.05 mcg/kg/min norepinephrine or less.

Claim (Index 29):
The method of  claim 24 , wherein the patient has shock, distributive shock, cardiogenic shock, sepsis, or acute kidney injury.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 90.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14941301', '14575127', '15870139', '15380574', '15400275']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7281750520849611
- 35 USC 102 Novelty (BERT): 0.5335344139967104
- Combined Prediction Score: 0.7087109882761361
- Mean Citation Score: 289.19486
- Max Citation Score: 330.64838
- Similarity Product: 228.70364477059368

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test